Torus Biosystems

Torus Biosystems is a small biotechnology company based in Medford, Massachusetts, with a team of five employees. Founded in 2020, the company was spun out from the Wyss Institute for Biologically Inspired Engineering at Harvard University. Torus Biosystems is focused on developing and commercializing proprietary DNA/RNA detection technology. The company's technology has the potential to improve patient outcomes, combat antibiotic resistance, and promote antimicrobial stewardship. Torus Biosystems targets a variety of ambulatory settings, including hospital outpatient and emergency departments, as well as long-term care facilities. Torus Biosystems' technology is based on research conducted by Wyss Core Faculty member, Peng Yin, PhD, Professor, Department of Systems Biology, Harvard Medical School, and Wyss Alumnus David Zhang, PhD, Associate Professor of Bioengineering, Rice University. For more information about Torus Biosystems and its innovative solutions, please visit www.torus.bio. You can also connect with the company on Twitter and LinkedIn.